Co-infusion of donor adipose tissue-derived mesenchymal and hematopoietic stem cells helps safe minimization of immunosuppression in renal transplantation – single center experience-Reference-Cited by-同舟云学术

Co-infusion of donor adipose tissue-derived mesenchymal and hematopoietic stem cells helps safe minimization of immunosuppression in renal transplantation – single center experience

Published:2014-09-23 Issue:9 Volume:36 Page:1376-1384
ISSN:0886-022X
Container-title:Renal Failure
language:en
Short-container-title:Renal Failure

Author:

Vanikar Aruna V.,Trivedi Hargovind L.,Kumar Ashutosh,Gopal Saroj Chooramani,Patel Himanshu V.,Gumber Manoj R.,Kute Vivek B.,Shah Pankaj R.,Dave Shruti D.

Publisher

Informa UK Limited

Subject

Nephrology,Critical Care and Intensive Care Medicine,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/0886022X.2014.950931

Reference40 articles.

1. Operational Tolerance in Living-Related Renal Transplantation: A Single-Center Experience

2. In Pursuit of the Ultimate: The Initial Ahmedabad Journey Toward Transplantation Tolerance

3. Effect of co-transplantation of mesenchymal stem cells and hematopoietic stem cells as compared to hematopoietic stem cell transplantation alone in renal transplantation to achieve donor hypo-responsiveness

4. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adipose derived mesenchymal stem cells and their role in management of kidney diseases;Journal of Renal Injury Prevention;2024-01-29

2. The modern view on adipose tissue regenerative products potential in skin pathologies treatment;Genes & Cells;2023-10-03

3. Adipose tissue-derived human mesenchymal stromal cells can better suppress complement lysis, engraft and inhibit acute graft-versus-host disease in mice;Stem Cell Research & Therapy;2023-06-25

4. Toward transplantation tolerance with adipose tissue-derived therapeutics;Frontiers in Immunology;2023-04-28

5. Autologous Mesenchymal Stem Cells for Treatment of Chronic Active Antibody-Mediated Kidney Graft Rejection: Report of the Phase I/II Clinical Trial Case Series;Transplant International;2022-11-22